Showing 11-20 of 30 results for "".
HCM: Understanding the condition
https://pace-cme.org/programs/cme/HCM_Understanding_the_condition/16546/This educational program consists of three presentations on hypertrophic cardiomyopathy (HCM).Diagnosing HCM: What a cardiologist needs to know
https://pace-cme.org/programs/cme/Diagnosing_HCM_What_a_cardiologist_needs_to_know/16547/This educational program consists of three presentations on hypertrophic cardiomyopathy (HCM).Navigating therapeutic approaches in HCM: Unravelling recent evidence
https://pace-cme.org/programs/cme/navigating-therapeutic-approaches-in-hcm-unravelling-recent-evidence/24531/Hypertrophic cardiomyopathy (HCM) presents multiple challenges in the diagnosis, prognosis, and treatment of patients with this disease. In this series, recent evidence and insights will be unraveled on the epidemiology, clinical features, pathophysiology, and new treatment options in HCM. MoreovEvaluation of the complex cardiac pathophysiology in HCM
https://pace-cme.org/programs/cme/evaluation-of-the-complex-cardiac-pathophysiology-in-hcm/26491/Hypertrophic cardiomyopathy (HCM) presents multiple challenges in the diagnosis, prognosis, and treatment of patients with this disease. In this series, recent evidence and insights will be unraveled on the epidemiology, clinical features, pathophysiology, and new treatment options in HCM. MoreovRecommendations on the management of HCM in guidelines: European vs. American views
https://pace-cme.org/programs/cme/recommendations-on-the-management-of-hcm-in-guidelines-european-vs-american-views/26493/Hypertrophic cardiomyopathy (HCM) presents multiple challenges in the diagnosis, prognosis, and treatment of patients with this disease. In this series, recent evidence and insights will be unraveled on the epidemiology, clinical features, pathophysiology, and new treatment options in HCM. MoreovMyosin inhibitors: recent clinical data and applications in HCM and HF
https://pace-cme.org/programs/cme/myosin-inhibitors-recent-clinical-data-and-applications-in-hcm-and-hf/26492/Hypertrophic cardiomyopathy (HCM) presents multiple challenges in the diagnosis, prognosis, and treatment of patients with this disease. In this series, recent evidence and insights will be unraveled on the epidemiology, clinical features, pathophysiology, and new treatment options in HCM. MoreovEpidemiology and clinical features of HCM
https://pace-cme.org/programs/cme/epidemiology-and-clinical-features-of-hcm/26490/Hypertrophic cardiomyopathy (HCM) presents multiple challenges in the diagnosis, prognosis, and treatment of patients with this disease. In this series, recent evidence and insights will be unraveled on the epidemiology, clinical features, pathophysiology, and new treatment options in HCM. Moreov- Cardiac myosin inhibitor reduces need for septal reduction therapy in obstructive HCMhttps://pace-cme.org/congress-coverage/acc22/cardiac-myosin-inhibitor-reduces-need-for-septal-reduction-therapy-in-obstructive-hcm/17498/3' education - Apr. 2, 2022 - Prof. Milind Desai, MD
- Emerging therapies in HCM: The potential role of cardiac myosin inhibitorshttps://pace-cme.org/topics/hypertrophic-cardiomyopathy/emerging-therapies-in-hcm-the-potential-role-of-cardiac-myosin-inhibitors/17528/10' education - May 4, 2022 - Ahmad Masri, MD and prof. Deepak Bhatt, MD
HCM and heart failure: is your patient at risk?
https://pace-cme.org/programs/cme/hcm-and-heart-failure-your-patient-risk/16265/This educational program consists of three presentations on HF and HCM.